Recent Updates
Recently added Catalysts
PYPD

PolyPid to Present at the JMP Securities 2022 Life Sciences Conference

Key Takeaway: PETACH TIKVA, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will present at the JMP Securities 2022 Life Sciences Conference, which i
Price reaction · baseline $160.5 (2022-06-01 close) · hit after-hours · 1 other PYPD headline(s) in the window, move may be shared
day 0 close
-2.6%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+50%
120-day peak, hindsight
Typical move
4.8%
average across 4 past catalysts
Lead asset
D-PLEX
Phase 3 · Surgical Site Infection

Full Press Release Details

PETACH TIKVA, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will present at the JMP Securities 2022 Life Sciences Conference, which is being held in New York City, on June 15-16, 2022.
JMP Securities 2022 Life Sciences Conference:
Presentation Date: Wednesday, June 15, 2022
Presentation Time: 11:00 AM Eastern Time
Investors interested in meeting with PolyPid during the conference should contact their JMP representative.
References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. PolyPid is not responsible for the contents of third-party websites.
Dikla Czaczkes Akselbrad
Last updated: Jun 2, 2022